US Stock MarketDetailed Quotes
GBIO Generation Bio
- 1.100
- -0.090-7.56%
Close Dec 23 16:00 ET
- 1.100
- 0.0000.00%
Post 19:12 ET
73.47MMarket Cap-0.50P/E (TTM)
1.250High1.080Low345.93KVolume1.210Open1.190Pre Close395.40KTurnover0.71%Turnover RatioLossP/E (Static)66.79MShares4.65052wk High0.70P/B53.70MFloat Cap0.75052wk Low--Dividend TTM48.82MShs Float55.720Historical High--Div YieldTTM14.28%Amplitude0.750Historical Low1.142Avg Price1Lot Size
Generation Bio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.49%-19.55M | -186.81%-21.54M | -14.52%-31.7M | 48.52%-52.75M | -8.59%-24.98M | -21.58%-24.9M | 205.41%24.81M | 21.89%-27.68M | -11.57%-102.45M | -10.58%-23M |
| Net income from continuing operations | 45.83%-15.31M | 34.23%-20.43M | -132.26%-74.54M | 7.34%-126.61M | -8.58%-35.19M | 9.71%-28.27M | 18.09%-31.07M | 8.30%-32.09M | -14.68%-136.64M | -4.72%-32.41M |
| Operating gains losses | ---- | ---- | ---- | -34.15%27K | ---- | ---- | ---- | ---- | -82.70%41K | -7.14%13K |
| Depreciation and amortization | -8.74%1.18M | -3.95%1.26M | -1.35%1.31M | 2.59%5.26M | -1.56%1.33M | -5.21%1.29M | 7.52%1.32M | 11.11%1.33M | 13.20%5.13M | 15.54%1.35M |
| Other non cash items | --619K | --1.63M | 237,079.17%56.92M | ---- | ---- | --0 | --0 | --24K | ---- | ---- |
| Change In working capital | -454.34%-7.92M | -111.01%-5.58M | -1,448.37%-17.06M | 5,018.26%53.54M | 76.14%5.43M | -135.67%-1.43M | 2,904.93%50.63M | 85.74%-1.1M | -74.95%1.05M | -21.22%3.09M |
| -Change in receivables | -173.44%-875K | -102.73%-1.34M | --0 | -802.53%-3.57M | ---3.3M | -123.14%-320K | 2,854.44%48.97M | ---48.92M | ---395K | --0 |
| -Change in prepaid assets | 6,338.89%1.16M | -34.34%413K | -215.37%-878K | 190.46%3.16M | 20.55%1.75M | 100.98%18K | 124.51%629K | 243.31%761K | -355.23%-3.49M | 68.02%1.45M |
| -Change in payables and accrued expense | -100.42%-4K | -47.26%673K | -195.57%-10.27M | 1,009.31%5.37M | 336.74%6.62M | -5.46%953K | 30.74%1.28M | 15.03%-3.48M | -116.47%-591K | -46.11%1.52M |
| -Change in other current assets | -305.08%-2.02M | -61.32%914K | -55.30%1.06M | -298.51%-9.21M | -941.94%-14.94M | -76.27%984K | 44.53%2.36M | 181.55%2.38M | 58.90%4.64M | 97.99%1.77M |
| -Change in other current liabilities | 8.83%-836K | -101.56%-3.49M | -545.72%-2.92M | 1,737.34%16.19M | 1,198.43%18.18M | -32.32%-917K | -150.59%-1.73M | 446.03%654K | 123.80%881K | -152.29%-1.66M |
| -Change in other working capital | -148.93%-5.34M | -212.84%-2.75M | -108.55%-4.06M | --41.6M | ---2.88M | ---2.15M | ---880K | --47.5M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.49%-19.55M | -186.81%-21.54M | -14.52%-31.7M | 48.52%-52.75M | -8.59%-24.98M | -21.58%-24.9M | 205.41%24.81M | 21.89%-27.68M | -11.57%-102.45M | -10.58%-23M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 147.80%12.71M | -50.48%12.09M | 90.15%-553K | 94.96%-9.7M | 89.60%-1.91M | -110.74%-26.58M | 115.38%24.42M | -101.72%-5.62M | -199.72%-192.52M | -356.75%-18.4M |
| Net PPE purchase and sale | 92.46%-46K | 106.20%90K | -154.04%-1.92M | 15.95%-7.4M | -571.55%-4.58M | 6.30%-610K | 69.00%-1.45M | 72.88%-755K | -50.37%-8.8M | 75.94%-682K |
| Net investment purchase and sale | 149.10%12.75M | -53.61%12M | 128.08%1.37M | 98.75%-2.3M | 115.05%2.67M | -117.11%-25.97M | 116.79%25.87M | ---4.86M | -192.37%-183.71M | -277.14%-17.71M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 147.80%12.71M | -50.48%12.09M | 90.15%-553K | 94.96%-9.7M | 89.60%-1.91M | -110.74%-26.58M | 115.38%24.42M | -101.72%-5.62M | -199.72%-192.52M | -356.75%-18.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 97.71%-3K | 136.36%234K | -100.35%-125K | 175.75%35.82M | -7.23%77K | -101.41%-131K | -97.20%99K | 68,692.31%35.77M | -93.95%12.99M | -80.92%83K |
| Net common stock issuance | --0 | --0 | --0 | 191.26%36M | --0 | --0 | --0 | --36M | -94.17%12.36M | --0 |
| Proceeds from stock option exercised by employees | --13K | ---- | ---- | -56.67%546K | -33.70%179K | --0 | ---- | ---- | -66.40%1.26M | -39.73%270K |
| Net other financing activities | 87.79%-16K | 88.43%-31K | 45.18%-125K | -15.53%-729K | 45.45%-102K | 66.75%-131K | ---268K | -356.00%-228K | 33.93%-631K | -1,338.46%-187K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 97.71%-3K | 136.36%234K | -100.35%-125K | 175.75%35.82M | -7.23%77K | -101.41%-131K | -97.20%99K | 68,692.31%35.77M | -93.95%12.99M | -80.92%83K |
| Net cash flow | ||||||||||
| Beginning cash position | -79.66%30.65M | -60.67%39.86M | -26.93%72.24M | -74.04%98.86M | -29.34%99.05M | -8.11%150.66M | -70.43%101.34M | -74.04%98.86M | 486.44%380.84M | -64.43%140.18M |
| Current changes in cash | 86.74%-6.84M | -118.68%-9.21M | -1,405.97%-32.38M | 90.56%-26.63M | 35.10%-26.82M | -117.05%-51.61M | 127.60%49.32M | 106.50%2.48M | -189.26%-281.97M | -212.95%-41.32M |
| End cash Position | -75.96%23.81M | -79.66%30.65M | -60.67%39.86M | -26.93%72.24M | -26.93%72.24M | -29.34%99.05M | -8.11%150.66M | -70.43%101.34M | -74.04%98.86M | -74.04%98.86M |
| Free cash flow | 23.01%-19.64M | -192.27%-21.55M | -18.23%-33.62M | 45.94%-60.14M | -24.80%-29.56M | -20.72%-25.51M | 182.77%23.35M | 25.61%-28.43M | -13.78%-111.25M | -0.20%-23.69M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
